Gordan Vujanić

8.5k total citations
152 papers, 4.4k citations indexed

About

Gordan Vujanić is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Gordan Vujanić has authored 152 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Molecular Biology, 81 papers in Pulmonary and Respiratory Medicine and 28 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Gordan Vujanić's work include Renal and related cancers (113 papers), Renal cell carcinoma treatment (70 papers) and Urological Disorders and Treatments (16 papers). Gordan Vujanić is often cited by papers focused on Renal and related cancers (113 papers), Renal cell carcinoma treatment (70 papers) and Urological Disorders and Treatments (16 papers). Gordan Vujanić collaborates with scholars based in United Kingdom, Germany and Netherlands. Gordan Vujanić's co-authors include Bengt Sandstedt, Kathy Pritchard‐Jones, Anna Kelsey, Norbert Graf, Ivo Leuschner, Jan de Kraker, D. Harms, Marry M. van den Heuvel‐Eibrink, Neil J. Sebire and Harm van Tinteren and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Gordan Vujanić

145 papers receiving 4.3k citations

Peers

Gordan Vujanić
Comparison fields: 5 of 115
  • Molecular Biology 3.3k
  • Pulmonary and Respiratory Medicine 2.3k
  • Pediatrics, Perinatology and Child Health 1.1k
  • Surgery 578
  • Urology 468
Replace Max J. Coppes with:
Max J. Coppes Canada
Marcio H. Malogolowkin United States
Christophe Bergeron France
Günter Janetschek Austria
H. B. Marsden United Kingdom
Milton H. Donaldson United States
Wataru W. Sutow United States
Khaled S. Hafez United States
Toshiro Terachi Japan
K. Miller Germany
Max J. Coppes Canada View profile →
Citations per field, relative to Gordan Vujanić
Gordan Vujanić · 1×
Citations per year, relative to Gordan Vujanić
Gordan Vujanić · 1×

Countries citing papers authored by Gordan Vujanić

Since Specialization
Citations

This map shows the geographic impact of Gordan Vujanić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordan Vujanić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordan Vujanić more than expected).

Fields of papers citing papers by Gordan Vujanić

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gordan Vujanić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordan Vujanić. The network helps show where Gordan Vujanić may publish in the future.

Co-authorship network of co-authors of Gordan Vujanić

This figure shows the co-authorship network connecting the top 25 collaborators of Gordan Vujanić. A scholar is included among the top collaborators of Gordan Vujanić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gordan Vujanić. Gordan Vujanić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1
Omission of adjuvant chemotherapy in patients with completely necrotic Wilms tumor stage I and radiotherapy in stage III: The 30‐year SIOP‐RTSG experience
2024 ·Pediatric Blood & Cancer ·Gordan Vujanić, Norbert Graf, Ellen D’Hooghe, Kathy Pritchard‐Jones, Christophe Bergeron, Harm van Tinteren, Rhoikos Furtwängler, (unknown)
1
2
Stage I epithelial or stromal type Wilms tumors are low risk tumors: An analysis of patients treated on the SIOP‐WT‐2001 protocol in the UK‐CCLG and GPOH studies (2001–2020)
2023 ·Cancer ·Ellen D’Hooghe, Rhoikos Furtwängler, Tanzina Chowdhury, Christian Vokuhl, Reem Al‐Saadi, Kathy Pritchard‐Jones, Norbert Graf, Gordan Vujanić
2
3
Teratoma‐associated and so‐called pure Wilms tumour of the ovary represent two separate tumour types with distinct molecular features
2023 ·Histopathology ·F. Kommoss, Anne‐Sophie Chong, María Apellániz-Ruiz, Gulisa Turashvili, Kay J. Park, Krisztina Hanley, Elvis Terci Valera, Andreas von Deimling, Gordan Vujanić, W. Glenn McCluggage, William D. Foulkes
2
4
How we approach paediatric renal tumour core needle biopsy in the setting of preoperative chemotherapy: A Review from the SIOP Renal Tumour Study Group
2022 ·Pediatric Blood & Cancer ·Thomas J. Jackson, Hervé J. Brisse, Kathy Pritchard‐Jones, Kayo Nakata, Carlo Morosi, (unknown), Sabine Irtan, Gordan Vujanić, Marry M. van den Heuvel‐Eibrink, Norbert Graf, Tanzina Chowdhury, (unknown)
16
5
Treatment of patients with stage I focal anaplastic and diffuse anaplastic Wilms tumour: A report from the SIOP-WT-2001 GPOH and UK-CCLG studies
2022 ·European Journal of Cancer ·William Mifsud, Rhoikos Furtwängler, Christian Vokuhl, Ellen D’Hooghe, Kathy Pritchard‐Jones, Norbert Graf, Gordan Vujanić
3
6
Pathology of Wilms' tumour in International Society of Paediatric Oncology (SIOP) and Children's oncology group (COG) renal tumour studies: Similarities and differences
2022 ·Histopathology ·Gordan Vujanić, (unknown), Ellen D’Hooghe, (unknown), Paola Collini, Elizabeth J. Perlman
20
7
Prognostic significance of histopathological response to preoperative chemotherapy in unilateral Wilms' tumor: An analysis of 899 patients treated on the SIOP WT 2001 protocol in the UK‐CCLG and GPOH studies
2021 ·International Journal of Cancer ·Gordan Vujanić, Ellen D’Hooghe, Norbert Graf, Christian Vokuhl, Reem Al‐Saadi, Tanzina Chowdhury, Kathy Pritchard‐Jones, Rhoikos Furtwängler
11
8
Dataset for the reporting of nephrectomy specimens for Wilms' tumour treated with preoperative chemotherapy: recommendations from the International Society of Paediatric Oncology Renal Tumour Study Group
2021 ·Histopathology ·Gordan Vujanić, Ellen D’Hooghe, Christian Vokuhl, Paola Collini
3
9
Renal Tumors of Childhood—A Histopathologic Pattern-Based Diagnostic Approach
2020 ·Cancers ·Ariadne H.A.G. Ooms, Gordan Vujanić, Ellen D’Hooghe, Paola Collini, (unknown), Christian Vokuhl, Norbert Graf, Marry M. van den Heuvel‐Eibrink, Ronald R. de Krijger
32
10
Publisher Correction: The UMBRELLA SIOP–RTSG 2016 Wilms tumour pathology and molecular biology protocol
2019 ·Nature Reviews Urology ·(unknown), Gordan Vujanić, Manfred Gessler, Ariadne H.A.G. Ooms, Paola Collini, Aurore Coulomb L’Herminé, Ellen D’Hooghe, Ronald R. de Krijger, Daniela Perotti, Kathy Pritchard‐Jones, Christian Vokuhl, Marry M. van den Heuvel‐Eibrink, Norbert Graf
4
11
Evaluation of needle biopsy as a potential risk factor for local recurrence of Wilms tumour in the SIOP WT 2001 trial
2019 ·European Journal of Cancer ·Sabine Irtan, Harm van Tinteren, Norbert Graf, Marry M. van den Heuvel‐Eibrink, Hugo A. Heij, Christophe Bergeron, Beatriz de Camargo, Tomás Acha, Filippo Spreafico, Gordan Vujanić, Mark Powis, Bruce Okoye, (unknown), Jan Godziński, Kathy Pritchard‐Jones
21
12
Prognostic significance of age in 5631 patients with Wilms tumour prospectively registered in International Society of Paediatric Oncology (SIOP) 93-01 and 2001
2019 ·PLoS ONE ·Janna A. Hol, Marta López‐Yurda, Harm van Tinteren, Martine van Grotel, Jan Godziński, Gordan Vujanić, Foppe Oldenburger, Beatriz de Camargo, Gema Ramírez, Christophe Bergeron, Kathy Pritchard‐Jones, Norbert Graf, Marry M. van den Heuvel‐Eibrink
28
13
The UMBRELLA SIOP–RTSG 2016 Wilms tumour pathology and molecular biology protocol
2018 ·Nature Reviews Urology ·(unknown), Gordan Vujanić, Manfred Gessler, Ariadne H.A.G. Ooms, Paola Collini, Aurore Coulomb L’Herminé, Ellen D’Hooghe, Ronald R. de Krijger, Daniela Perotti, Kathy Pritchard‐Jones, Christian Vokuhl, Marry M. van den Heuvel‐Eibrink, Norbert Graf
151
14
TREATMENT OF RELAPSED WILMS TUMOUR (WT) PATIENTS: EXPERIENCE WITH TOPOTECAN
2014 ·Data Archiving and Networked Services (DANS) ·(unknown), (unknown), (unknown), Harm van Tinteren, Gordan Vujanić, Kathy Pritchard‐Jones, Lisa Howell, Norbert Graf, (unknown), (unknown), Filippo Spreafico
3
15
Doxorubicin can be safely omitted from the treatment of stage II/III, intermediate risk histology wilms tumour: results of the siop wt 2001 randomised trial [Abstract]
2011 ·ORCA Online Research @Cardiff (Cardiff University) ·Kathy Pritchard‐Jones, Norbert Graf, Christophe Bergeron, Beatriz de Camargo, (unknown), Bengt Sandstedt, Ivo Leuschner, Gordan Vujanić, Liliane Boccon‐Gibod, Jan Godziński, Foppe Oldenburger, Harm van Tinteren, Jan de Kraker
1
16
Is the absolute blastema volume after preoperative chemotherapy in nephroblastoma relevant for prognosis? [Abstract]
2011 ·ORCA Online Research @Cardiff (Cardiff University) ·Norbert Graf, Harm van Tinteren, Kathy Pritchard‐Jones, Christophe Bergeron, Bengt Sandstedt, Ivo Leuschner, Gordan Vujanić, Liliane Boccon‐Gibod, Marry van den Heuvel‐Eibrink, Beatriz de Camargo, Filippo Spreafico, Foppe Oldenburger, Jan Godziński, Jan de Kraker
4
17
Subtype-Specific FBXW7 Mutation and MYCN Copy Number Gain in Wilms' Tumor
2010 ·Clinical Cancer Research ·Richard D. Williams, Reem Al‐Saadi, Tasnim Chagtai, Sergey Popov, Boo Messahel, Neil J. Sebire, Manfred Gessler, Jenny Wegert, Norbert Graf, Ivo Leuschner, Michael Hubank, Chris Jones, Gordan Vujanić, Kathy Pritchard‐Jones, (unknown), (unknown)
55
18
Expression of Hepatocyte Growth Factor and Its Receptor Met in Wilms' Tumors and Nephrogenic Rests Reflects Their Roles in Kidney Development
2009 ·Clinical Cancer Research ·Raisa Vuononvirta, Neil J. Sebire, Boo Messahel, Nina Perusinghe, Jorge S. Reis‐Filho, Kathy Pritchard‐Jones, Gordan Vujanić, Chris Jones
5
19
CLEAR CELL SARCOMA OF THE KIDNEY (CCSK) - COMBINED 20 YEAR EXPERIENCE OF THERAPUETIC OUTCOMES FROM UNITED KINGDOM (UK) AND FRANCE
2009 ·UCL Discovery (University College London) ·Simon Stoneham, (unknown), (unknown), (unknown), Gordan Vujanić, L Boccon-Gibod, Gill Levitt, Kathy Pritchard‐Jones, (unknown), Christophe Bergeron
1
20
Blastemal/stromal expression of IGF1R in Wilms tumours is driven by increased copy number and correlates with relapse
2006 ·Cancer Research ·Rachael Natrajan, Suzanne E. Little, Jorge S. Reis‐Filho, William Warren, Boo Messahel, Marie‐Anne Bründler, Gordan Vujanić, Kathy Pritchard‐Jones, Chris Jones
1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Max J. Coppes Breakdown of academic impact, for papers by Marcio H. Malogolowkin Breakdown of academic impact, for papers by Christophe Bergeron Breakdown of academic impact, for papers by Günter Janetschek Breakdown of academic impact, for papers by H. B. Marsden Breakdown of academic impact, for papers by Milton H. Donaldson Breakdown of academic impact, for papers by Wataru W. Sutow Breakdown of academic impact, for papers by Khaled S. Hafez Breakdown of academic impact, for papers by Toshiro Terachi Breakdown of academic impact, for papers by K. Miller
Rankless by CCL
2026